CA2524818A1 - Peptides de proteine kinase c utilises pour le sevrage - Google Patents
Peptides de proteine kinase c utilises pour le sevrage Download PDFInfo
- Publication number
- CA2524818A1 CA2524818A1 CA002524818A CA2524818A CA2524818A1 CA 2524818 A1 CA2524818 A1 CA 2524818A1 CA 002524818 A CA002524818 A CA 002524818A CA 2524818 A CA2524818 A CA 2524818A CA 2524818 A1 CA2524818 A1 CA 2524818A1
- Authority
- CA
- Canada
- Prior art keywords
- peptide
- seq
- pkc
- withdrawal
- isozyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/11—Protein-serine/threonine kinases (2.7.11)
- C12Y207/11013—Protein kinase C (2.7.11.13)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Addiction (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
L'invention concerne une composition destinée à être utilisée pour gérer le sevrage d'une substance engendrant une dépendance. La composition comprend un ou plusieurs peptides possédant une activité spécifique pour isozyme .epsilon. et/ou ? de protéine kinase C (PKC). Le ou les peptide(s) peuvent être administrés avant, pendant ou après l'administration de la substance engendrant la dépendance. L'invention concerne aussi un kit possédant au moins un récipient contenant un peptide possédant une activité spécifique pour isozyme .epsilon. et/ou ? de protéine kinase C (PKC) et un mode d'emploi.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2003/016070 WO2004103266A2 (fr) | 2003-05-16 | 2003-05-16 | Peptides de proteine kinase c utilises pour le sevrage |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2524818A1 true CA2524818A1 (fr) | 2004-12-02 |
Family
ID=33476226
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002524818A Abandoned CA2524818A1 (fr) | 2003-05-16 | 2003-05-16 | Peptides de proteine kinase c utilises pour le sevrage |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1631309A4 (fr) |
JP (1) | JP4675109B2 (fr) |
AU (1) | AU2003241559A1 (fr) |
CA (1) | CA2524818A1 (fr) |
WO (1) | WO2004103266A2 (fr) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002519391A (ja) * | 1998-07-06 | 2002-07-02 | オー. メッシング,ロバート | 痛みを処置するための、プロテインキナーゼcイプシロンの阻害剤の使用 |
US6376467B1 (en) * | 1998-10-09 | 2002-04-23 | The Regents Of The University Of California | Use of inhibitors of protein kinase C epsilon to treat pain |
US6717030B2 (en) * | 1998-07-06 | 2004-04-06 | The Regents Of The University Of California | Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse |
US6248904B1 (en) * | 1998-07-21 | 2001-06-19 | Cytovia, Inc. | Fluorescence dyes and their applications for whole-cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof |
CA2785889A1 (fr) * | 2002-04-22 | 2003-10-30 | The Board Of Trustees Of The Leland Stanford Junior University | Inhibiteurs peptidiques de la proteine kinase c |
-
2003
- 2003-05-16 WO PCT/US2003/016070 patent/WO2004103266A2/fr active Application Filing
- 2003-05-16 JP JP2004572186A patent/JP4675109B2/ja not_active Expired - Fee Related
- 2003-05-16 AU AU2003241559A patent/AU2003241559A1/en not_active Abandoned
- 2003-05-16 CA CA002524818A patent/CA2524818A1/fr not_active Abandoned
- 2003-05-16 EP EP03731305A patent/EP1631309A4/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU2003241559A1 (en) | 2004-12-13 |
JP4675109B2 (ja) | 2011-04-20 |
EP1631309A2 (fr) | 2006-03-08 |
WO2004103266A2 (fr) | 2004-12-02 |
JP2006525948A (ja) | 2006-11-16 |
WO2004103266A8 (fr) | 2005-10-20 |
EP1631309A4 (fr) | 2010-04-28 |
WO2004103266A3 (fr) | 2005-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8507440B2 (en) | Protein kinase C peptides for use in withdrawal | |
CA2481512C (fr) | Inhibiteurs peptidiques de la proteine kinase c.gamma. pour la ge stion de la douleur | |
Tian et al. | Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat | |
Roumy et al. | Neuropeptide FF, pain and analgesia | |
Gerrits et al. | Drug dependence and the endogenous opioid system | |
Narita et al. | Role of protein kinase C in desensitization of spinal δ‐opioid‐mediated antinociception in the mouse | |
Steele et al. | A possible role for the brain renin-angiotensin system in the regulation of LH secretion | |
Marco et al. | Neuropeptide FLFQPQRFamide receptors within the ventral mesenchephalon and dopaminergic terminal areas: Localization and functional antiopioid involvement | |
Pastor et al. | Effect of selective antagonism of mu (1)-, mu (1/2)-, mu (3)-, and delta-opioid receptors on the locomotor-stimulating actions of ethanol | |
WO2005032575A1 (fr) | Peptides de la proteine kinase c utiles pendant le sevrage | |
CA2524818A1 (fr) | Peptides de proteine kinase c utilises pour le sevrage | |
Szekely | Opioid peptides in substance abuse | |
Menendez et al. | Calmodulin inhibitors induce spinal analgesia in rats | |
JP2010090176A (ja) | 離脱症状における使用のためのプロテインキナーゼcペプチド | |
Buccafusco et al. | Effect of intrathecal pretreatment with the neurokinin receptor antagonist CP-99994 on the expression of naloxone-precipitated morphine withdrawal symptoms | |
WO1997049422A1 (fr) | Procede d'utilisation de ligands du recepteur opioïde kappa | |
Attila et al. | The antiopioid peptide, neuropeptide FF, enhances the effects of acute morphine on the cerebral monoamines in rats | |
Khasar et al. | Sympathetic-independent bradykinin mechanical hyperalgesia induced by subdiaphragmatic vagotomy in the rat | |
Hutcheson et al. | Use of selective antagonists and antisense oligonucleotides to evaluate the mechanisms of BUBU antinociception | |
Yoburn | Opioid antagonist-induced upregulation and functional supersensitivity | |
Gulati | Differential effects of intrahypothalamic administration of opioids on food intake in naive and tolerant rats | |
Prupas | Modulation of behavioural and neurochemical responses associated with morphine tolerance by ultra-low doses of opioid receptor antagonists. | |
Herz | Opposing tonically active endogenous opioid system modulating the mesolimbic dopamine reward pathway | |
AU2012216402A1 (en) | Peptide inhibitors of protein kinase Cy for pain management | |
Zachariou | Studies on the modulation of the basal and evoked release of substance P in the dorsal horn of the rat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |